# Inmune Bio, Inc.: filings

INMB · Nasdaq · CIK 1711754 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inmb.md) · [Financials](/companies/inmb/financials.md) · [Filings](/companies/inmb/filings.md) · [Insiders](/companies/inmb/insiders.md)

## Reports and events: 345 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 284, 4 117, 10-Q 23, 424B5 15, CORRESP 15, UPLOAD 15, 3 13, DEF 14A 9, EFFECT 9, 10-K 8, 4/A 7, SC 13D/A 6, 424B3 5, 8-A12B/A 5, 8-K/A 5, S-3 5, FWP 4, S-8 4, SCHEDULE 13G/A 4, DRSLTR 3, S-1 3, S-1/A 3, SC 13D 3, SC 13G 3, 8-A12B 2, D 2, DRS/A 2, PRE 14A 2, SC 13G/A 2, SCHEDULE 13G 2, 10-K/A 1, 144 1, CERT 1, DEFA14A 1, DEFR14A 1, DRS 1, POS AM 1, S-3/A 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 09:00 ET | [8-K](/filings/0001213900-26-111207.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-111207 |
| 2026-09-14 | 16:05 ET | [8-K](/filings/0001213900-26-099700.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-099700 |
| 2026-08-06 | 16:07 ET | [10-Q](/filings/0001213900-26-086135.md) | Quarterly report, period 2026-06-30 | 0001213900-26-086135 |
| 2026-07-31 | 16:06 ET | [8-K](/filings/0001213900-26-083961.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-083961 |
| 2026-07-01 | 07:16 ET | [8-K](/filings/0001213900-26-073983.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-073983 |
| 2026-06-23 | 16:05 ET | [8-K](/filings/0001213900-26-071082.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-071082 |
| 2026-06-17 | 16:01 ET | [8-K](/filings/0001213900-26-069611.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-069611 |
| 2026-06-02 | 16:00 ET | [8-K](/filings/0001213900-26-064144.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-064144 |
| 2026-05-14 | 16:05 ET | [8-K](/filings/0001213900-26-056599.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-056599 |
| 2026-05-07 | 16:17 ET | [10-Q](/filings/0001213900-26-053338.md) | Quarterly report, period 2026-03-31 | 0001213900-26-053338 |
| 2026-05-05 | 16:30 ET | [8-K](/filings/0001213900-26-052231.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-052231 |
| 2026-04-23 | 16:06 ET | [DEF 14A](/filings/0001213900-26-047080.md) | Proxy statement, period 2026-06-16 | 0001213900-26-047080 |
| 2026-03-30 | 17:29 ET | [10-K](/filings/0001213900-26-036370.md) | Annual report, period 2025-12-31 | 0001213900-26-036370 |
| 2026-02-27 | 09:14 ET | [8-K](/filings/0001213900-26-021120.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-021120 |
| 2026-02-23 | 16:05 ET | [8-K](/filings/0001213900-26-019321.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-019321 |
| 2026-02-19 | 16:00 ET | [8-K](/filings/0001213900-26-018396.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-018396 |
| 2026-02-13 | 16:00 ET | [8-K](/filings/0001213900-26-016385.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-016385 |
| 2026-01-27 | 16:00 ET | [8-K](/filings/0001213900-26-008204.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-008204 |
| 2025-12-23 | 16:00 ET | [8-K](/filings/0001213900-25-125282.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-125282 |
| 2025-12-19 | 16:30 ET | [8-K](/filings/0001213900-25-123880.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-123880 |
| 2025-12-10 | 16:00 ET | [8-K](/filings/0001213900-25-120067.md) | 1.02 Termination of a material agreement | 0001213900-25-120067 |
| 2025-12-08 | 16:00 ET | [8-K](/filings/0001213900-25-119217.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001213900-25-119217 |
| 2025-12-05 | 16:00 ET | [8-K](/filings/0001213900-25-118699.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-118699 |
| 2025-12-03 | 16:15 ET | [8-K](/filings/0001213900-25-117828.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-117828 |
| 2025-11-28 | 13:00 ET | [8-K](/filings/0001213900-25-115921.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-115921 |
| 2025-11-18 | 16:30 ET | [8-K](/filings/0001213900-25-112136.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-112136 |
| 2025-11-10 | 17:13 ET | [8-K](/filings/0001213900-25-108315.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-108315 |
| 2025-10-30 | 16:15 ET | [8-K](/filings/0001213900-25-104154.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-104154 |
| 2025-10-30 | 16:10 ET | [10-Q](/filings/0001213900-25-104141.md) | Quarterly report, period 2025-09-30 | 0001213900-25-104141 |
| 2025-10-28 | 16:01 ET | [8-K](/filings/0001213900-25-103068.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-103068 |
| 2025-10-14 | 16:03 ET | [DEF 14A](/filings/0001213900-25-098715.md) | Proxy statement, period 2025-11-18 | 0001213900-25-098715 |
| 2025-10-14 | 16:00 ET | [8-K](/filings/0001213900-25-098702.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-098702 |
| 2025-09-30 | 16:05 ET | [8-K](/filings/0001213900-25-093930.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-093930 |
| 2025-08-07 | 16:17 ET | [8-K](/filings/0001213900-25-073089.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-073089 |
| 2025-08-07 | 16:08 ET | [10-Q](/filings/0001213900-25-073077.md) | Quarterly report, period 2025-06-30 | 0001213900-25-073077 |
| 2025-07-29 | 16:34 ET | [8-K](/filings/0001213900-25-068745.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-068745 |
| 2025-07-25 | 16:47 ET | [8-K](/filings/0001213900-25-067791.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-067791 |
| 2025-06-30 | 16:31 ET | [8-K](/filings/0001213900-25-059690.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-059690 |
| 2025-06-30 | 08:01 ET | [8-K](/filings/0001213900-25-059252.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-059252 |
| 2025-06-26 | 16:00 ET | [8-K](/filings/0001213900-25-058380.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-058380 |
| 2025-06-10 | 16:00 ET | [8-K](/filings/0001213900-25-053051.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-053051 |
| 2025-05-14 | 16:00 ET | [8-K](/filings/0001213900-25-043270.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-043270 |
| 2025-05-08 | 16:18 ET | [8-K](/filings/0001213900-25-041082.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-25-041082 |
| 2025-05-08 | 16:15 ET | [10-Q](/filings/0001213900-25-041072.md) | Quarterly report, period 2025-03-31 | 0001213900-25-041072 |
| 2025-05-07 | 17:20 ET | [8-K](/filings/0001213900-25-040727.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-25-040727 |
| 2025-05-05 | 16:46 ET | [8-K](/filings/0001213900-25-039733.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-039733 |
| 2025-04-21 | 16:06 ET | [DEF 14A](/filings/0001213900-25-033742.md) | Proxy statement, period 2025-05-28 | 0001213900-25-033742 |
| 2025-04-16 | 16:01 ET | [8-K](/filings/0001213900-25-032565.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-032565 |
| 2025-04-14 | 16:30 ET | [8-K](/filings/0001213900-25-031590.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-031590 |
| 2025-04-09 | 10:13 ET | [8-K](/filings/0001213900-25-030129.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-030129 |

Page 1 of 7. [Older](/companies/inmb/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 07:41 ET. No prices; not investment advice.